Effect of Over-the-counter Dietary Supplements on Kidney Stone Risk
Completed · Not applicable
Conditions studied: Hyperoxaluria
In brief
The purpose of this study is to ascertain whether certain supplements promote excessive urinary oxalate excretion and increase the risk for calcium oxalate kidney stones. Supplements that enhance urinary oxalate excretion, as a result of their oxalate concentration or from some other mechanism (e.g., providing substrate for oxalate biosynthesis) will be identified by the investigators.
Key facts
- Study ID
- NCT02404701
- Run by
- University of Wisconsin, Madison
- People needed
- 45
- Starts
- 2015-02-01
- Expected to finish
- 2016-10-01
- Last updated by the study team
- 2016-10-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- At least 18 years of age, no prior personal history of kidney stones
You may not qualify if…
- Personal history of kidney stones (by subjects' report); known allergy to any of the dietary supplements to be used in the study (by subjects' report); short bowel; active ulcerative colitis or irritable bowel disease; Crohns or Celiac disease; renal tubular acidosis; current use of topiramate or other carbonic anhydrase inhibitor, steroids, allopurinol, thiazide diuretics, or supplemental ascorbic acid >250 mg/day.
Where it is running
- Department of Urology, School of Medicine & Public Health, University of Wisconsin — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.